Occult Mechanisms of Brain Dysfunction
It is clear from Dr. Millichap’s presentation that important advances in the diagnosis and treatment of seizure disorders and minimal brain dysfunction syndromes have been realized in recent years. Unfortunately, significant progress toward the companion goal of prevention remains seriously hampered by our poor understanding of the etiology and pathogenesis of these conditions. Genetic factors undoubtedly play at least a predispositional role in many cases, but the potential contribution of an adverse environment deserves constant emphasis, particularly in that corrective measures are more easily brought to bear upon the environment than upon the gene. Dr. Nair, in discussing the toxic effects of drugs upon the developing CNS, touched upon an important theme worth reiterating here; that, in contrast to the gross malformations which characteristically result from exposure to toxic agents in early stages of development, exceedingly subtle forms of brain damage capable of defying current methods of detection may occur from exposure in later developmental stages. Dr. Millichap indicated, and I think many would agree, that the more carefully one examines children with minimal brain dysfunction, the more convinced one becomes that some sort of subtle brain damage underlies these conditions.
KeywordsBrain Damage Arcuate Nucleus Brain Dysfunction Acidic Amino Acid Sulphur Amino Acid
Unable to display preview. Download preview PDF.
- Everly, J.L., 1971, Light microscopic examination of MSG-induced lesions in brain of fetal and neonatal rats, Anat. Rec. 169: 312.Google Scholar
- Gaines, T.B. and Kimbrough, R.D., 1971, The oral and dermal toxicity of hexachlorophene, Paper read at the 10th annual meeting of the Society of Toxicology in Washington, D.C., March 7–11.Google Scholar
- Johnston, N. and Reynolds, W.A., 1972, Incidence and extent of brain lesions in mice following ingestion of MSG, Anat. Rec. 172: 354.Google Scholar
- Knittle, J.L. and Ginsberg-Feller, F., 1970, Cellular and metabolic alterations in obese rats treated with monosodium glutamate during the neonatal period, Bulletin Am. Peds. Soc. Gen. Meeting, Program Abstracts, p. 6.Google Scholar
- Matsuyan, S., 1970, Studies on experimental obesity in mice treated with MSG. Jap. J. Vet. Science 32: 206.Google Scholar
- Murakami, U. and Inouye, M., 1971, Brain lesions in the mouse fetus caused by maternal administration of monosodium glutamate, Congenital Anomalies 11: 171.Google Scholar
- Yoshida, T., Tada, K., Mizuno, T., Wada, Y., Akabane, J., Ogasawara, J., Minagawa, A., Morikawa, T. and Okamura, T., 1964, A sex-linked disorder with mental and physical retardation characterized by cerebrocortical atrophy and increase of glutamic acid in the cerebrospinal fluid, Tohoku J. Med. Sci. 83: 26.Google Scholar